🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study evaluates the effect of a single oral dose of bosutinib on the si...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-05
Trial ID
NCT02102633
Treatments Being Tested
The purpose of this study is to look at how safe and effective is bosulif i...
Status
Recruiting
Location
Pfizer New York
Start Date
2025-01-20
Trial ID
NCT06297161
Treatments Being Tested
The purpose of this prospective, single-institution observational study is ...
Status
Completed
Location
UNC Hospital
Start Date
2019-06-20
Trial ID
NCT03885830
This study is intended to estimate the bioavailability of a single 100 mg b...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2022-01-19
Trial ID
NCT05032690
Treatments Being Tested
This study will determine the maximum-tolerated dose (MTD) for oral bosutin...
Status
Completed
Location
Augusta University Georgia Cancer Center
Start Date
2019-12-10
Trial ID
NCT03023319
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
This is a research study in 2 parts assessing the following parameters of t...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-09
Trial ID
NCT00959946
Treatments Being Tested
Prospective, open label, multicenter, phase II study evaluating correlation...
Status
Completed
Location
C. H. U. de Gran Canaria Dr. Negrín
Start Date
2015-05
Trial ID
NCT02445742
Treatments Being Tested
To study the efficacy and safety of combination of Ro-Peg-interferon-α2b (R...
Status
Completed
Location
Aalborg university hospital
Start Date
2019-03-25
Trial ID
NCT03831776
Treatments Being Tested
The aim of this study was to evaluate the real-world treatment patterns, he...
Status
Completed
Location
Novartis
Start Date
2024-02-27
Trial ID
NCT07188428